Prevest Denpro

Which are the latest news on Prevest Denpro?

Why is Prevest Denpro Ltd falling/rising?

As of 05-Sep, Prevest Denpro Ltd's stock price is declining, currently at 381.85, down 2.01%. The stock has underperformed the Sensex and shows poor long-term growth prospects, with a significant annual decline of 33.26% and negative investor sentiment despite increased participation.

As of 05-Sep, Prevest Denpro Ltd's stock price is falling, currently at 381.85, reflecting a decrease of 7.85 or 2.01%. This decline follows a trend reversal after three consecutive days of gains. The stock has underperformed relative to the benchmark Sensex, with a 1-week performance of -1.28% compared to the Sensex's -0.97%. <BR><BR>In terms of longer-term performance, the stock has seen a significant decline of 33.26% over the past year, which is starkly contrasted by the Sensex's modest drop of 5.21% during the same period. Additionally, the company's operating profit growth has been lackluster, with an annual growth rate of only 16.34% over the last five years, indicating poor long-term growth prospects. <BR><BR>Today, the stock touched an intraday low of Rs 376, marking a decrease of 3.52%. It is also trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically signals a bearish trend. Furthermore, despite a rise in investor participation, with delivery volume increasing by 342.2% against the 5-day average, the overall sentiment remains negative due to the company's flat results and below-par performance metrics, such as the lowest recorded ROCE and inventory turnover ratio. <BR><BR>In summary, the combination of poor long-term growth, recent price declines, and underperformance relative to benchmarks are contributing to the falling stock price of Prevest Denpro Ltd.

Who are in the management team of Prevest Denpro?

The management team of Prevest Denpro includes Atul Modi (Chairman & Managing Director), Namrata Modi (Whole Time Director & CFO), Sai Kalyan Surapaneni (Executive Director), Niharika Modi (Non-Executive Director), and several independent directors: Nikhil Shrikant Bobade, Sudeep Haralakatte Murthy, and Pardeep Gandotra, along with Executive Director Vaibhav Munjal. They oversee the company's operations and strategic direction.

The management team of Prevest Denpro includes the following individuals:<BR><BR>1. **Atul Modi** - Chairman & Managing Director<BR>2. **Namrata Modi** - Whole Time Director & CFO<BR>3. **Sai Kalyan Surapaneni** - Executive Director<BR>4. **Niharika Modi** - Non-Executive Director<BR>5. **Nikhil Shrikant Bobade** - Independent Non-Executive Director<BR>6. **Sudeep Haralakatte Murthy** - Independent Non-Executive Director<BR>7. **Vaibhav Munjal** - Executive Director<BR>8. **Pardeep Gandotra** - Independent Non-Executive Director<BR><BR>This team is responsible for overseeing the operations and strategic direction of the company.

What does Prevest Denpro do?

Prevest Denpro Ltd is a micro-cap manufacturer of dental materials, incorporated in 1999, with recent net sales of 19 Cr and a net profit of 6 Cr as of June 2026. The company has a market cap of INR 462 Cr and key financial metrics include a P/E ratio of 21.00 and a return on equity of 16.42%.

Overview: <BR>Prevest Denpro Ltd is a leading manufacturer of dental materials in the healthcare services industry, categorized as a micro-cap company.<BR><BR>History: <BR>Prevest Denpro Ltd was incorporated on May 05, 1999, with the Registrar of Companies in Jammu & Kashmir. The latest quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 19 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: 6 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 462 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 21.00 <BR>Industry P/E: 112 <BR>Dividend Yield: 0.26% <BR>Debt Equity: -0.65 <BR>Return on Equity: 16.42% <BR>Price to Book: 3.75 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Who are the peers of the Prevest Denpro?

Peers of Prevest Denpro include One Global Serv, Health X Platform, Hemant Surgical, Nureca, Take, Bilcare, and QMS Medical. One Global Serv leads in management quality and growth, while Prevest Denpro has below-average growth and the lowest 1-year return at -32.25%.

Peers: The peers of Prevest Denpro are One Global Serv, Health X Platfor, Hemant Surgical, Nureca, Take, Bilcare, and QMS Medical.<BR><BR>Quality Snapshot: Excellent management risk is observed at One Global Serv and the rest have either Average or Below Average management risk. Growth is Excellent at One Global Serv, Good at Hemant Surgical, and Below Average at Prevest Denpro, Health X Platfor, Nureca, Take, and the rest. Capital Structure is Excellent at One Global Serv and Prevest Denpro, Good at Nureca, and Below Average at Health X Platfor, Take, Bilcare, QMS Medical, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is One Global Serv at 111.18%, while Prevest Denpro has the lowest at -32.25%. Nureca also shows a strong 1-year return at 41.92%. Additionally, Take and QMS Medical have negative six-month returns.

How big is Prevest Denpro?

As of 31st August, Prevest Denpro Ltd has a market capitalization of 462.00 Cr, with recent net sales of 75.11 Cr and a net profit of 21.72 Cr. Shareholder's funds are 124.80 Cr, and total assets amount to 133.19 Cr as of March 2026.

As of 31st August, Prevest Denpro Ltd has a market capitalization of 462.00 Cr, which classifies it as a Micro Cap company.<BR><BR>In the latest 4 quarters, Prevest Denpro reported Net Sales of 75.11 Cr and a Net Profit of 21.72 Cr.<BR><BR>The latest annual period for the balance sheet is March 2026, with Shareholder's Funds amounting to 124.80 Cr and Total Assets of 133.19 Cr.

Should I buy, sell or hold Prevest Denpro Ltd?

Has Prevest Denpro Ltd declared dividend?

Yes, Prevest Denpro Ltd has declared a 10% dividend, with an ex-date of September 4, 2026. However, total returns over recent periods have been generally negative, particularly in the short term.

Prevest Denpro Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Ex-date: 04 Sep 26<BR><BR>Dividend Yield: 0.26%.<BR><BR>Total Returns by Period:<BR>In the last 3 months, the price return was -7.14%, the dividend return was 0.25%, resulting in a total return of -6.89%.<BR><BR>Over the last 6 months, the price return was -13.41%, the dividend return was 0.22%, leading to a total return of -13.19%.<BR><BR>For the 1-year period, the price return was -28.84%, the dividend return was 0.37%, which resulted in a total return of -28.47%.<BR><BR>In the 2-year period, the price return was -25.44%, with a dividend return of 0.51%, culminating in a total return of -24.93%.<BR><BR>Over the last 3 years, the price return was -16.43%, the dividend return was 0.62%, leading to a total return of -15.81%.<BR><BR>In the 4-year period, the price return was 14.04%, the dividend return was 0.96%, resulting in a total return of 15.0%.<BR><BR>Finally, in the 5-year period, the price return was 0%, the dividend return was 0%, leading to a total return of 0.0%.<BR><BR>Overall, while Prevest Denpro Ltd has declared a dividend, the total returns over various periods indicate a generally negative performance, particularly in the shorter time frames, despite a positive return in the 4-year period.

Are Prevest Denpro Ltd latest results good or bad?

Prevest Denpro Ltd's latest Q4 FY26 results are positive, showing a 23.31% increase in net profit and improved operating margins. However, the stock has declined 18.03% over the past year and is considered "very expensive" at a price-to-earnings ratio of 24.02, prompting caution among investors.

Prevest Denpro Ltd's latest results for Q4 FY26 can be considered good overall. The company reported a net profit of ₹5.82 crores, which represents a significant increase of 23.31% quarter-on-quarter and 13.23% year-on-year. Additionally, revenue for the quarter reached ₹18.94 crores, reflecting a growth of 2.60% from the previous quarter and 2.66% year-on-year.<BR><BR>The operating margin also improved to 36.48%, marking the highest level in seven quarters, which indicates enhanced operational efficiency. This margin expansion is a positive sign, as it suggests that the company is effectively managing costs while maintaining pricing power in its dental materials segment.<BR><BR>However, it's important to note that despite these strong quarterly results, the stock has faced challenges over the past year, declining by 18.03%. This underperformance relative to the broader market raises some concerns among investors, particularly regarding the company's valuation, which is perceived as "very expensive" at a price-to-earnings ratio of 24.02 times.<BR><BR>In summary, while the latest results demonstrate strong operational performance and profitability, the stock's recent decline and high valuation multiples suggest that investors may need to exercise caution moving forward.

When is the next results date for Prevest Denpro Ltd?

The next results date for Prevest Denpro Ltd is August 11, 2026.

The next results date for Prevest Denpro Ltd is scheduled for August 11, 2026.

Is Prevest Denpro overvalued or undervalued?

As of December 3, 2025, Prevest Denpro is considered overvalued with a valuation grade of expensive, a PE ratio of 27.29, and a year-to-date return of -24.41%, underperforming against the Sensex's 8.92%.

As of 3 December 2025, the valuation grade for Prevest Denpro has moved from very expensive to expensive. The company is currently considered overvalued. Key ratios include a PE Ratio of 27.29, an EV to EBITDA of 19.44, and a Price to Book Value of 4.63. <BR><BR>In comparison to peers, Prevest Denpro's PE ratio is lower than that of Poly Medicure, which stands at 53.52, but higher than BPL, which is at 5.92. The PEG ratio of Prevest Denpro is 1.47, indicating that while growth is priced in, it does not justify the current valuation when compared to its peers. Additionally, the company's stock has underperformed against the Sensex, with a year-to-date return of -24.41% compared to the Sensex's 8.92%.

How has been the historical performance of Prevest Denpro?

Prevest Denpro's historical performance from March 2024 to March 2025 shows growth in net sales to 63.03 Cr, operating profit to 26.16 Cr, and profit after tax to 18.16 Cr, alongside an increase in cash reserves to 60.00 Cr, indicating overall positive financial trends.

Answer:<BR>The historical performance of Prevest Denpro shows a positive trend in key financial metrics from March 2024 to March 2025.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Prevest Denpro reported net sales of 63.03 Cr, an increase from 56.43 Cr in the previous year. The total operating income also rose to 63.03 Cr from 56.43 Cr, with raw material costs slightly increasing to 14.08 Cr from 13.76 Cr. Total expenditure, excluding depreciation, grew to 40.94 Cr from 36.58 Cr, leading to an operating profit (PBDIT) of 26.16 Cr, up from 22.71 Cr. Profit before tax increased to 24.25 Cr from 21.43 Cr, resulting in a profit after tax of 18.16 Cr, compared to 16.14 Cr the previous year. The earnings per share improved to 15.13 from 13.45, while the operating profit margin slightly decreased to 35.05% from 35.18%. The profit after tax margin increased to 28.81% from 28.6%. On the balance sheet, shareholder's funds rose to 105.57 Cr from 88.62 Cr, with total assets increasing to 112.53 Cr from 94.82 Cr. Cash and cash equivalents at year-end improved to 60.00 Cr from 48.00 Cr, indicating a net cash inflow of 12.00 Cr compared to 9.00 Cr in the prior year. Overall, the financial performance of Prevest Denpro reflects growth in sales, profits, and cash reserves.

Is Prevest Denpro technically bullish or bearish?

As of November 7, 2025, the technical trend is mildly bearish, supported by bearish signals from the MACD, Dow Theory, and Bollinger Bands, despite a mildly bullish daily moving average.

As of 7 November 2025, the technical trend has changed from sideways to mildly bearish. The current stance is mildly bearish, driven by the weekly and monthly MACD and Dow Theory indicators, both indicating a bearish outlook. The Bollinger Bands also reflect a bearish sentiment on both weekly and monthly time frames. Although the daily moving averages show a mildly bullish signal, this is overshadowed by the overall bearish indicators. The stock has underperformed against the Sensex over multiple periods, further supporting the bearish view.

Who are the top shareholders of the Prevest Denpro?

The top shareholders of Prevest Denpro include Atul Modi, the largest individual shareholder with 37.52%, and a foreign institutional investor holding 0.63%. Public shareholders include Pushpa Kumari Pankaj Prasoon at 2.47%, while individual investors collectively hold 19.54%, with no pledged promoter holdings or mutual fund investments.

The top shareholders of Prevest Denpro include the promoters, with Atul Modi being the largest individual shareholder, holding 37.52% of the shares. Additionally, there is one foreign institutional investor (FII) that holds 0.63% of the shares. Among public shareholders, Pushpa Kumari Pankaj Prasoon is the highest, with a holding of 2.47%. Individual investors collectively hold 19.54% of the company. There are no pledged promoter holdings and no mutual funds currently invested in the company.